The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Primary, secondary, and quality-of-life endpoint results from PREVAIL, a phase 3 study of enzalutamide in men with metastatic castration resistant prostate cancer (mCRPC).
Andrew J. Armstrong
Consultant or Advisory Role - Amgen (U); Astellas/Medivation (U); Bristol-Myers Squibb (U); Dendreon (U); Janssen (U); Sanofi (U)
Honoraria - Dendreon; Pfizer; Sanofi
Research Funding - Active Biotech; Dendreon; Janssen; Medivation; Novartis; Pfizer; Sanofi
Bertrand Tombal
Consultant or Advisory Role - Amgen; Ferring
Honoraria - Astellas Pharma; Medivation
Cora N. Sternberg
Honoraria - Astellas Pharma; Bayer; Ipsen; Johnson & Johnson; Millennium
Celestia S. Higano
Consultant or Advisory Role - Bayer (U); Dendreon (U); Johnson & Johnson (U); Medivation/Astellas (U)
Research Funding - Algeta; Aragon Pharmaceuticals; Dendreon; Medivation/Astellas; Sanofi
Dana E. Rathkopf
Research Funding - Janssen; Medivation
Yohann Loriot
Consultant or Advisory Role - Astellas Pharma (U)
Research Funding - Astellas Pharma
Fred Saad
Consultant or Advisory Role - Astellas Pharma; Janssen; Medivation; Sanofi
Anthony M. Joshua
Consultant or Advisory Role - Astellas Pharma (U)
Johann Sebastian De Bono
Consultant or Advisory Role - Medivation/Astellas (U)
Honoraria - Medivation/Astellas
Peter M. Venner
Honoraria - Astellas Pharma; Janssen; Novartis; Pfizer
Research Funding - Astellas Pharma; Janssen; Lilly; Novartis; Pfizer
Joan Carles
No relevant relationships to disclose
Paul N. Mainwaring
No relevant relationships to disclose
Christopher P. Evans
Consultant or Advisory Role - Medivation (U)
Stock Ownership - Medivation
Research Funding - Medivation
Sarah B. Noonberg
Employment or Leadership Position - Medivation
Harry H. Mansbach
Employment or Leadership Position - Medivation
Suman Bhattacharya
Employment or Leadership Position - Medivation
Frank Perabo
Employment or Leadership Position - Astellas Pharma
De Phung
Employment or Leadership Position - Astellas Pharma
Tomasz M. Beer
Research Funding - Astellas Pharma; Cougar Biotechnology; Janssen; Medivation